Ronner P, Cheong E, Khalid P, Tuman R W, Matschinsky F M
Department of Biochemistry and Biophysics, School of Medicine, University of Pennsylvania, Philadelphia 19104-6015.
Diabetes. 1991 Jul;40(7):878-84. doi: 10.2337/diab.40.7.878.
We examined the effect of the hypoglycemic drug linogliride on hormone release from the in vitro perfused rat pancreas. Linogliride stimulated insulin release in the absence of glucose either in the presence or absence of a physiological mixture of amino acids. In addition, linogliride inhibited amino acid-induced glucagon release. Half-maximal effects of linogliride on insulin and glucagon release were achieved at concentrations as low as 26 and 3 microM, respectively. The effects of linogliride on hormone release largely resembled those of tolbutamide. In the absence of amino acids, the stimulation of insulin release by linogliride or tolbutamide was transient. When the pancreas had been preperfused for 20 min with tolbutamide, linogliride no longer had an effect on hormone release. Likewise, tolbutamide remained without effect in pancreases preperfused with linogliride. These data suggest that linogliride and tolbutamide may have a similar mechanism of action.
我们研究了降糖药物利诺格列对体外灌注大鼠胰腺激素释放的影响。无论有无生理氨基酸混合物,利诺格列在无葡萄糖存在的情况下均可刺激胰岛素释放。此外,利诺格列可抑制氨基酸诱导的胰高血糖素释放。利诺格列对胰岛素和胰高血糖素释放的半数最大效应分别在低至26 μM和3 μM的浓度下实现。利诺格列对激素释放的影响在很大程度上类似于甲苯磺丁脲。在无氨基酸的情况下,利诺格列或甲苯磺丁脲对胰岛素释放的刺激是短暂的。当胰腺用甲苯磺丁脲预灌注20分钟后,利诺格列对激素释放不再有影响。同样,在预先用利诺格列灌注的胰腺中,甲苯磺丁脲也没有作用。这些数据表明利诺格列和甲苯磺丁脲可能具有相似的作用机制。